Limin Chemical Co., Ltd., Xinjiang Xinrong Renhe Equity Investment Co., Ltd. and Jiaxing Jinyu Xinwei Equity Investment Partnership (Limited Partnership) completed the acquisition of Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd. from Beijing Xinrong Investment Management Co., Ltd. and ENN Ecological Holdings Co.,Ltd..
June 23, 2019
Share
Limin Chemical Co., Ltd. (SZSE:002734) agreed to acquire Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd. from Beijing Xinrong Investment Management Co., Ltd. and others on October 10, 2018. Limin Chemical Co., Ltd., Xinjiang Xinrong Renhe Equity Investment Co., Ltd. and Jiaxing Jinyu Xinwei Equity Investment Partnership (Limited Partnership) (the buyers) signed an agreement to acquire Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd. from Beijing Xinrong Investment Management Co., Ltd. and ENN Ecological Holdings Co.,Ltd. (SHSE:600803) (the sellers) for approximately CNY 760 million on October 11, 2018. Under the terms of transaction, Limin Chemical Co., Ltd. will acquire 60% stake, Xinjiang Xinrong Renhe Equity Investment Co., Ltd. will acquire 25% stake and Jiaxing Jinyu Xinwei Equity Investment Partnership (Limited Partnership) will acquire 15% stake in n Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd. 50% of consideration will be paid within 20 working days from the date of full satisfaction of the relevant equity transfer agreement or within a certain period of time agreed by the buyers and the sellers, and within two working days before the application for industrial and commercial change registration, the buyers shall pay the second equity transfer amount to the sellers account totaling CNY 380 million. The transaction is subject to approval of shareholders of Limin Chemical Co., Ltd. and needs to be reviewed by the operator for anti-monopoly. The transaction has been approved by the Board of Limin Chemical Co., Ltd. and ENN Ecological Holdings Co.,Ltd.
Limin Chemical Co., Ltd., Xinjiang Xinrong Renhe Equity Investment Co., Ltd. and Jiaxing Jinyu Xinwei Equity Investment Partnership (Limited Partnership) completed the acquisition of Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd. from Beijing Xinrong Investment Management Co., Ltd. and ENN Ecological Holdings Co.,Ltd. (SHSE:600803) on June 24, 2019. The equity transfer price was paid. The directors, supervisors and senior management personnel of Hebei Weiyuan Biochemical Co., Ltd., Hebei Weiyuan Animal Pharmaceutical Co., Ltd. and Inner Mongolia Xinweiyuan Biochemical Co., Ltd have not been employed by ENN Ecological Holdings Co.,Ltd and its controlling shareholder.
Limin Group Co., Ltd., formerly Limin Chemical Co., Ltd., is a China-based company principally engaged in the research, development, production and sales of pesticides and preparations. The Company mainly provides germicide products, including mancozeb, cymoxanil, fosetyl-aluminum and pyrimethanil, among others. It also provides pesticides such as thiacloprid and other formulations, and herbicides such as mesotrione. The Company distributes its products within domestic market and to overseas markets.
LIMIN GROUP CO.,LTD. 
